News Novavax delays timeline for approval, production of COVID-19 vaccine to late 2021 By - May 11, 2021 0 146 Facebook Twitter Pinterest WhatsApp The Maryland-based company has repeatedly pushed back production forecasts and has struggled to access raw materials and equipment needed to make its vaccine.